Recurrent airway obstruction in horses;Obstrucción recurrente de las vías aéreas en el caballo

Archivos de Medicina Veterinaria

Volumn 38, Issue 3, 2006, Pages

  Moran G ^a,c   Araya, O ^b   Folch, H ^a  

^a Facultad de Medicina   (Chile)

^b UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^c NONE   (Chile)

Author keywords

Airways; Horses; Inflammation; RAO; Review

Indexed keywords

ANIMALIA; EQUIDAE;

EID: 33846553659     PISSN: 0301732X     EISSN: 07176201     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Akdis M, C Schmidt-Weber, M Jutel, CA Akdis, K Blaser. 2004. Mechanism of allergen immunotherapy. Clin Exp All Rev 4, 56-60.
2. Araya O. 1999. Enfermedades respiratorias crónicas en caballos y su relación con estabulación deficiente en Chile. Curso de afecciones respiratorias en caballos, Hospital Veterinario. Universidad Austral de Chile, Valdivia, Chile.
3. Araya O, L Zaror. 1995. Determinación de esporas de hongos y ácaros de vida libre en heno y paja en criaderos de caballos chilenos. Arch Med Vet 2, 41-45.
4. Art T, D Duvivier, D Votion, N Anciaux, S Vandenput, W Bayly, P Lekeux. 1998. Does an acute COPD crisis modify the cardiorespiratory and ventilatory adjustment to exercise in horses? J Appl Physiol 84, 845-852.
5. Bandeira-Melo C, A Herbst, P Welle. 2001. Eotaxin: Contributing to the diversity of eosinophil recruitment and activation. Am J Resp Cell Mol Biol 24, 653-657.
6. Barnes PJ, K Fan Chung, C Page. 1998. Inflammatory mediators of asthma: An Update. Pharmacological Reviews 50, 515-596.
7. Barnes PJ. 1992. Modulation of neurotransmission in airways. Physiol Rev 72, 699-729.
8. Barnes PJ. 1996. Pathophysiology of asthma. Br J Clin Pharmacol 42, 3-10.
9. Bureau F, G Bonizzi, N Kirschvink, S Delhalle, D Desmecht, MP Merville, V Bours, P Lekeux. 2000a. Correlation between nuclear factor-κB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. AM J Resp Crit Care Med 161, 1314-1321
10. Bureau F. S Delhalle, G Bonizzi, L Fievez, S Dogne, N Kirschvink, A Vanderplasschen, MP Merville, V Bours, P Lekeux. 2000b. Mechanisms of persistent NF-κB activity in the bronchi of an animal model of asthma. J Immunol 165, 5822-5830.
11. Campbell E, S Kunkel, R Strieter, N Luckas. 2000. Differential role of Il-18 in allergic airway disease: Induction of eotaxin by resident cell populations exacerbates eosinophil accumulation. J Immunol 164, 1096-1102.
12. Chand N, P Eyre. 1975. Classification and biological distribution of histamine receptor subtypes. Agents Actions 5, 277-295.
13. Chung K, P Barnes. 1999. Cytokines in asthma. Thorax 54, 825-857.
14. Clarke AG. 1987. Stable environment in relation to the control of respiratory diseases. Horses Management. Ed J Hickman, Pp 125-174.
15. Clarke AG, T Madelin. 1987. Technique for assessing respiratory health hazards from hay and other source materials. Equine Vet J 19, 442-447.
16. Corrigan CJ, CM Hawrylowicz, P Lavender, TH Lee. 2004. Glucocorticoid-resistant asthma. Clin Exp All Rev 4, 200-204.
17. Couëtil LL, FS Rosenthal, CM Simpson. 2000. Forced expiration: a test for airflow obstruction in horses. J Appl Physiol 88, 1870-1879.
18. Derksen FJ, NE Robinson, PJ Armstrong, RF Slocombe. 1985. Airway reactivity in ponies with recurrent airway obstruction ("heaves"). J appl Physiol 58, 598-604.
19. Derksen FJ, CM Brown, I Sonia, BJ Darien, NE Robinson. 1989. Comparison of transtracheal aspirate and bronchoalveolar lavage cytology in 50 horses with chronic lung disease. Equine Vet J 21, 598-604.
20. Derksen FJ, R Slocombe, P Gray. 1992. Exercise induced pulmonary hemorrage in horses with experimentally induced allergic lung disease. Am J Vet Res 53, 15-21.
21. Dixon PM. 1999. Equine Chonic Obstructive Pulmonary Disease (COPD). Curso de afecciones respiratoria en caballos, Hospital Veterinario. Universidad Austral de Chile, Valdivia, Chile.
22. Eder C, I Curik, G Brem, R Crameri, I Bodo, F Habe, S Lazary, J Solkner, E Marti. 2001. Influence of environmental and genetics factors on allergen-specific immunoglobulin-E levels in sera from Lipizzan horses. Equine Vet J 7, 714-20.
23. Falvs A, K Merety. 1992. Histamine: An early messenger in inflamatory and immune responses. Immunol Today 13, 154-156.
24. Feder L, D Stelts, D Chapman, D Manfra, Y Crawley, H Jones, M Minnicozzi, X Fernandez, T Paster, R Egan, W Kreutner, T Kung. 1997. Role of nitric oxide on eosinophilic lung inflammation in allergic mice. AM J Respir Cell Mol Biol 17, 436-442.
25. a edición. Masson-Salvat Medicina.
26. Franchini M, U Gill, R Von Fellenberg, VV Bracher. 2000. Interleukin- 8 concentration and neutrophil chemotactic activity in bronchoalveolar lavage fluid of horses with chronic obstructive pulmonary disease following exposure to hay. Am J Vet Res 11, 1369-74
27. Fryer A, D Jacoby. 1998. Muscarinic receptors and control of airway smooth muscle. Am J Respir Crit Care Med 158, S154-S160.
28. Gerber H. 1973. Chronic Pulmonary Disease in the Horses. Equine Vet J 5, 26-28.
29. Gerber H. 1989. The genetic basic of some equine diseases. Equine Vet J 21, 244-248.
30. Gerber V, NE Robinson, RJ Venta, J Rawson, AM Jefcoat, JA Hotchkiss. 2003. Mucin genes in horses airways: MUC5AC, but not MUC2, may play a role in recurrent airway obstruction. Equine Vet J 3, 252-7.
31. Gould HJ, BJ Sutton, AJ Beavil, RL Beavil, N McCloskey, HA Coker, D Fear, L Smurthwaite. 2003. The biology of IgE and the basis of allergy disease. Ann Rev Immunol 21, 579-628.
32. Griesenbach U, P Scheid, E Hillery, R DE Martin, L Huang, DM Geddes, EW Alton. 2000. Antiinflammatory gene therapy directed at the airway epithelium. Gene Ther 4, 306-13.
33. Hare JE, L Viel, PM O'Byrne, PD Conlon. 1994. Effect of sodium cromoglycate on light racehorses with elevated metachromatic cell numbers on broncheoalveolar lavage and reduced exercise tolerance. J Vet Pharmacol Ther 17, 237-244.
34. Hare JE, L Viel. 1998. Pulmonary eosinophilia associated with increased airway responsiveness in young racing horses. J Vet Intern Med 12, 163-170.
35. Harmegnies NF, DH Duvivier, SN Vandenput, T Art, PM Lekeux, DM Votion. 2002. Exercise-induced pulmonary perfusion redistribution in heaves. Equine Vet J 34, 478-84.
36. Hockenjos P, Y Mumenoglu, H Gerber. 1981. Zur möglichen aetiologischen Bedeutung von Heumilben für allergisch bedingte Lungenkrankeiten des Pferdes. Schwiez Arch Tierheilk 123, 129-136.
37. Hoffmann AM. 1999. Broncheoalveolar lavage technique and cytologic diagnosis of small airway inflammatory disease. Equine Vet Educ 11, 330-336.
38. Holcombe SJ, C Jackson, V Gerber, A Jefcoat, C Berney, S Eberhardt, E Robinson. 2001. Stabling is associated with airway inflammation in young Arabian horses. Equine Vet J 33, 244-249.
39. Honjo T, K Kinoshita, M Muramatsu. 2002. Molecular Mechanism of Class Switch Recombination: linkage with Somatic Hypermutation. Ann Rev Immunol 20, 165-196
40. Jackson CA, C Berney, AM Jefcoat, NE Robinson. 2000. Environmen and prednisone interactions in the treatment of recurrent airway obstruction (heaves). Equine Vet J 32, 432-438.
41. Jackson KA, JL Stott, DW Horohov, JL Watson. 2004. IL-4 induced CD23 (FceRII) up-regulation in equine peripheral blood mononuclear cells and pulmonary alveolar macrophages. Vet Immun Immunopath 101, 243-250.
42. Kinoshita K, T Honjo. 2001. Linking class-switch recombination with somatic hypermutation. Nat Rev Mol Biol 2, 493-503.
43. Kurup V, J Xia, R Crameri, D Rickaby, H Chol, S Fluckiger, K Blaser, C Dawson, K Kelly. 2001. Purified recombinant A. fumigatus allergens induce different response in mice. Clinical Inmumunol 98, 327-336.
44. Lapointe JM, JP Lavoie, AA Vrins. 1993. Effects of triamcinolone acetonide on pulmonary function and broncheoalveolar lavage cytologic features in horses with chronic obstructive pulmonary disease. Am J Ves Res 54, 1310-1316.
45. Lavoie JP, K Maghni, M Desnoyers, R Taha, JG Martin, Q Hamid. 2000. Brocheoalveolar cells from horses with "heaves" express a Th2-type cytokine profile. Proceedings of the Annual Veterinary Medical forum 18, Pp 751.
46. Lavoie JP, K Maghni, M Desnoyers, R Taha, J Martin, Q Hamid. 2001. Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile. Am J Respir Crit Care Med 164, 1410-1413.
47. Lekeux P, D Duvivier. 2001. Aerosol Therapy. International Veterinary Information Service. Ithaca, New York, USA.
48. Levine SJ. 1995. Bronchial epithelial cell-cytokine interactions in airways ephitelium. J Invest Med 43, 241-249.
49. McGorum B, J Ellison, R Cullen. 1998. Total and respirable dust endotoxin concentrations in three equine management systems. Equine Vet J 30, 430-434.
50. McGorum B, PM Dixon. 1994. The analysis and interpretation of equine bronchoalveolar lavage fluid (BALF) cytology. Equine Vet Educ 4, 203-209.
51. Marsh DG, A Lockhart, ST Holgate. 1993. The genetics of asthma. Blackwell Scientific Publications, Oxford, England.
52. Marti E, H Gerber, G Essich, J Oulehla, S Lazary. 1991. The genetic basic of equine allergic diseases. Chronic hypersensitivity bronchitis. Equine Vet J 23, 457-460.
53. Marti E, L Harwood. 2002. Genetics of human asthma and equine recurrent airway obstruction: can these two disease e compared? Pferdheikunde 18, 587-593.
54. Mekori Y, D Metcalfe. 1999. Mast Cell-T interactions. J Allergy Clin Immunol 104, 517-523.
55. Moore BR, JH Cox. 1996. Diagnostic use of broncheoalveolar lavage in horses. Equine Practice 5, 7-15.
56. Newton J, J Wood. 2002. Evidence of an association between inflammatory airway disease and EIPH in young Thoroughbreds during training. Equine Vet J 34, 417-24.
57. Pujols L, J Mullol, A Torrego, C Picado. 2004. Glucocoticoid receptors in human airway. Allergy 59, 1042-1052.
58. Olszewski MA, XY Zhang, NE Robinson. 1999. Pre-and postjunctional effects of inflammatory mediators in horses airways. Am J Physiol 277, L327-L333.
59. Robinson NE. 2001. International Workshop on Equine Chronic Airway Disease Michigan State University. Equine Vet J 33, 5-19.
60. Robinson NE. 2003. Current Therapy in Equine Medicine 4. Philadelpia. WB Saunders Co. USA.
61. Rush BR, AA Worster, MJ Flmino, CJ Matson, JE Hakala. 1998a. Alteration in adrenocortical function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropinate and dexamethasone, respectively. Am J Vet Res 8, 1044-7.
62. Rush BR, ES Raub, WS Rhoad, MJ Flamino, CJ Matson, JE Hakala, JR Gillespie. 1998b. Pulmonary function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropinate and dexamethasone, respectively. Am J Vet Res 8, 1039-43.
63. Rush BR, MJ Flamino, CJ Matson, JE Hakala, W Shuman. 1998c. Cytologic evaluation of bronchoalveolar lavage fluid from horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropinate and dexamethasone, respectively. Am J Vet Res 8, 1033-8.
64. Rush BR, ES Raub, MM Thomsen, EG Davis, CJ Matson, JE Hakala. 2000. Pulmonary function and adrenal gland suppression with incremental doses of aerosolized beclomethasone dipropionate in horses with recurrent airway obstruction. Am. J. Vet. Res 3, 359-64.
65. Saunders C, F Bureau, R Turlej, L Fievez, S Dogne, N Kirschvink, P Lekeux. 2001. Homodimer activity distal airway cells determines lung dysfuction in equine heaves. Vet Immunol Immonolpathol 80, 315-26
66. Saunders MA, JA Mitchell, PM Seldon, PJ Barnes, MA Giembyez, MG Belvisi. 1997. Release of granulocyte-macrophage colonystimulating factor by human cultured airway smooth muscle cells: Suppression by dexamethasone. Br J Pharmacol 120, 545-546.
67. Schapfer W. 1939. Untersusuchungen uber die Erblichkeit und das Wesen des Lungendampfes beim Pferd. Tierarztl Rundsch 45, 595-601.
68. Schleimer RP, CA Sterbinsky, CA Kaiser, DA Bickel, K Klunk, Ktomoika, W Newman, MA Luscinskas, MA Gimbrone, BW McIntire, BS Buchner. 1992. Interlukin-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: Association with expression of VCAM-1. J Immunol 148, 1086-1092.
69. Schultz J, J Arrang, M Garbarg, H Pollard, M Ruat. 1991. Histaminergic transmission in the mammalian brain. Physiol Rev 71, 1-51.
70. Steinke J, L Borish. 2001. Th2 cytokines and asthma Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonist. Resp Res 2, 66-70.
71. Soma LR, J Beech, NH Gerber. 1987. Effects of cromolyn in horses with cronic obstructive pulmonary disease. Vet Res Commun 11, 339-351.
72. Thomson JR, EA McPherson. 1981. Prophylactic effects of sodium cromoglycate on chronic obstructive pulmonary disease in the horses. Equine Vet J 13, 243-246.
73. Umland S, R Schleimer, S Johnston. 2002. Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. Pulmon Pharmacol & therapeutics 15, 35-50.
74. Vignola AM, AM Campbell, P Chanez, P Lacoste, F Michel, P Godard, J Bousquet. 1993. Activation of histamine by bronchial epithelial cells from nonasthmatic subjects. Am J Resp Crit Care Med 9, 411-417
75. Varner AE, WW Busse. 1996. Are you undertreating inflammation in asthma? J Resp Dis 17, 656-668.
76. Wagner B, G Siebenkotten, A Radbruch, W Leibold. 2001. Nucleotide sequence and restriction fragment length polymorphisms of the equine Ce gene. Vet Immun Immunopath 82, 193-202.
77. Wynn TA. 2003. IL-13 Effector Functions. Annu Rev Immnol 21, 425-456.
78. Yamauchi K, Y Martinet, P Basset, GA Fells, RG Crystal. 1988. High levels of transforming growth factor-B are present in the epitelial cell lining fluid of the normal human lower respiratory tract. Am Rev Resp Dis 137, 1360-1363
79. Zhang XY, NE Robinson, FX Zhu. 1999. Modulation of Ach release from airway cholinergic nerves in horses with recurrent airway obstruction. Lung Cell Mol Physiol 20, L7769-L775.